Hidehito Horinouchi

Alectinib in Resected <i>ALK</i> -Positive Non–Small-Cell Lung Cancer

Yi‐Long Wu, Rafał Dziadziuszko, Jin Seok Ahn et al. · New England Journal of Medicine · 2024 · 320 citations

Immunohistochemical status of PD-L1 in thymoma and thymic carcinoma

Yuki Katsuya, Yu Fujita, Hidehito Horinouchi et al. · Lung Cancer · 2015 · 172 citations

Medicine, Immunology, Immune Checkpoint Inhibitor +4

Reliability of Small Biopsy Samples Compared With Resected Specimens for the Determination of Programmed Death-Ligand 1 Expression in Non–Small-Cell Lung Cancer

Satoru Kitazono, Yutaka Fujiwara, Koji Tsuta et al. · Clinical Lung Cancer · 2015 · 136 citations

Non–small-cell Lung Cancer, Prognostic Biomarkers, Oncology +10

Identification of two novel mutations in the SLC25A13 gene and detection of seven mutations in 102 patients with adult-onset type II citrullinemia

Tomotsugu Yasuda, Naoki Yamaguchi, Keiko Kobayashi et al. · Human Genetics · 2000 · 131 citations

Mendelian Disorder, Genetic Disorder, Genetics +8

PD-L1 expression in neuroendocrine tumors of the lung

Kenjiro Tsuruoka, Hidehito Horinouchi, Yasushi Goto et al. · Lung Cancer · 2017 · 124 citations · Full text